NIPRO JMI Pharma Ltd.

Established | 2012 |
Market Share | 1.19% |
Growth | 21.82% |
Total generics | 116 |
Headquarter | Unique Heights (Level-6), 117, Kazi Nazrul Islam Avenue Dhaka-1217. |
Contact details | 55138726, 55138727, 55138728 |
Fax | 88-0255138725 |
NIPRO JMI Pharma Ltd (NJPL) is one of the robust and reputed pharmaceutical companies in Bangladesh. NIPRO JMI Pharma started its journey in 2012 with collaboration of NIPRO Corporation, a big giant MNC (Multinational Company) based in Japan. We are engaged in manufacturing and marketing of pharmaceuticals products in compliance with cGMP by WHO (World Health Organization).
NJP is dedicated to ensure its world class products and services through HCP (Healthcare professional) for the ailing humanity of the country and beyond. We focus on innovative ideas into our practices. We want to make our organization a national healthcare brand with global magnitude.
NJP is dedicated to ensure its world class products and services through HCP (Healthcare professional) for the ailing humanity of the country and beyond. We focus on innovative ideas into our practices. We want to make our organization a national healthcare brand with global magnitude.
Top brands
Doxophylline
Empagliflozin
Bilastine
Linagliptin + Metformin Hydrochloride
Racecadotril
Linagliptin
Vitamin B1, B6 & B12
Clonazepam
Empagliflozin + Metformin Hydrochloride
Fluticasone Furoate
Pregabalin
Iron Polymaltose Complex + Folic Acid + Zinc Sulfate
Betamethasone + Neomycin Sulphate (Topical)
Tiemonium Methylsulfate
Algae Calcium + Vitamin D3
Montelukast Sodium
Empagliflozin + Linagliptin
Azithromycin Dihydrate
Rabeprazole Sodium
Naproxen Sodium + Esomeprazole Magnesium